Jamous RM, Sweileh WM, El-Deen Abu Taha AS, Zyoud SH. Profiling patient attitudes to phosphate binding medication: a route to personalising treatment and adherence support. Survey of the use of phosphate binders in maintaining hemodialysis patients. Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research. Mechta Nielsen T, Frojk Juhl M, Feldt-Rasmussen B, Thomsen T. Regimen complexity and prescription adherence in dialysis patients. Neri L, Martini A, Andreucci VE, Gallieni M, Rey LA, Brancaccio D, et al. Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis. Martins MT, Silva LF, Kraychete A, Reis D, Dias L, Schnitman G, et al. Determinants of compliance behaviours among patients undergoing hemodialysis in Malaysia. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase. Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC. Adherence to long-term therapies: evidence for action. Effects of a nurse-led intensive education program on chronic renal failure patients with hyperphosphatemia. Phosphate-control adherence in hemodialysis patients: current perspectives. Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. Karamanidou C, Clatworthy J, Weinman J, Horne R. Nonadherence to medication therapy in haemodialysis patients: a systematic review. Ghimire S, Castelino RL, Lioufas NM, Peterson GM, Zaidi ST. Hyperphosphatemia management in patients with chronic kidney disease. KDIGO 2017 Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. Health care providers should provide efficient interventions enhancing knowledge and positive beliefs about phosphate binders in hemodialysis patients. ![]() ![]() Knowledge and beliefs about phosphate binders are crucial in improving patients’ phosphate binder adherence. 98) had better phosphate binder adherence.Ĭonclusion and recommendations: Phosphate binder adherence was poor in patients undergoing hemodialysis in China. In binary logistic regression, participants with higher knowledge about phosphate binder (OR = 10.73, 95%CI = 3.84, 29.97), higher beliefs about necessity of phosphate binder (OR = 1.23, 95%CI = 1.09, 1.39), and lower concerns about phosphate binder (OR =. Main findings: Results indicated that 54.4% of the participants did not adhere to phosphate binders. Descriptive statistics, Mann-Whitney U test, Chi-square test, and binary logistic regression were applied for statistical analysis. Data were collected using Chinese version of modified Medication Adherence Report Scale (MARS), modified Beliefs about Medicines Questionnaire (BMQ), modified Health Care Climate (HCC) Scale, and Phosphate Binder Knowledge Test (PBKT). Methods: A total of 158 participants receiving hemodialysis at two hemodialysis centers under a university in China were recruited via convenience sampling. Purpose: To study factors associated with phosphate binder adherence among patients undergoing hemodialysis in China.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |